ATE549345T1 - Verfahren zur herstellung von medrogeston - Google Patents

Verfahren zur herstellung von medrogeston

Info

Publication number
ATE549345T1
ATE549345T1 AT06700710T AT06700710T ATE549345T1 AT E549345 T1 ATE549345 T1 AT E549345T1 AT 06700710 T AT06700710 T AT 06700710T AT 06700710 T AT06700710 T AT 06700710T AT E549345 T1 ATE549345 T1 AT E549345T1
Authority
AT
Austria
Prior art keywords
medrogeston
producing
methylenepregn
medrogestone
heterogeneously
Prior art date
Application number
AT06700710T
Other languages
English (en)
Inventor
Jean-Luc Moutou
Benoit Rondot
Jean Lafay
Philippe Maillos
Original Assignee
Abbott Products Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott Products Gmbh filed Critical Abbott Products Gmbh
Application granted granted Critical
Publication of ATE549345T1 publication Critical patent/ATE549345T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J7/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
    • C07J7/0005—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21
    • C07J7/001—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group
    • C07J7/004—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group substituted in position 17 alfa
    • C07J7/0045—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group substituted in position 17 alfa not substituted in position 16
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Steroid Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
AT06700710T 2005-01-18 2006-01-17 Verfahren zur herstellung von medrogeston ATE549345T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US64405305P 2005-01-18 2005-01-18
EP05100267 2005-01-18
PCT/EP2006/050242 WO2006077209A1 (en) 2005-01-18 2006-01-17 Method for preparing medrogestone

Publications (1)

Publication Number Publication Date
ATE549345T1 true ATE549345T1 (de) 2012-03-15

Family

ID=34938526

Family Applications (1)

Application Number Title Priority Date Filing Date
AT06700710T ATE549345T1 (de) 2005-01-18 2006-01-17 Verfahren zur herstellung von medrogeston

Country Status (5)

Country Link
EP (1) EP1841778B1 (de)
JP (1) JP2008527022A (de)
AT (1) ATE549345T1 (de)
CA (1) CA2595317A1 (de)
WO (1) WO2006077209A1 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106983754A (zh) 2011-05-20 2017-07-28 国家医疗保健研究所 Cb1受体拮抗剂
RU2667065C2 (ru) 2012-11-28 2018-09-14 Энсэрм (Энститю Насьональ Де Ля Санте Э Де Ля Решерш Медикаль) Производные прегненолона
HU231125B1 (hu) 2016-12-16 2020-12-28 Richter Gedeon Nyrt. Ipari eljárás Nomegesztrol-acetát előállítására

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3170936A (en) * 1963-08-07 1965-02-23 American Home Prod Process for the preparation of 6, 17alpha-dimethyl-4, 6-pregnadiene-3, 20-dione
US3479342A (en) * 1965-03-25 1969-11-18 Smithkline Corp 6,6-ethylene pregnenes
DE3204281C1 (de) * 1982-02-05 1983-07-21 Schering Ag, 1000 Berlin Und 4619 Bergkamen Verfahren zur Herstellung von 6-Methyl-delta?-3-ketosteroiden
US5428151A (en) * 1994-05-05 1995-06-27 American Home Products Corporation Medrogestrone production

Also Published As

Publication number Publication date
JP2008527022A (ja) 2008-07-24
CA2595317A1 (en) 2006-07-27
EP1841778A1 (de) 2007-10-10
EP1841778B1 (de) 2012-03-14
WO2006077209A1 (en) 2006-07-27

Similar Documents

Publication Publication Date Title
DE502004009142D1 (de) Verfahren zur herstellung substituierter 3-aryl-butyl-aminverbindungen
ATE427965T1 (de) Antikírper gegen 25-hydroxyvitamin d
ATE517190T1 (de) Verfahren zur fermentativen herstellung von 1,5- diaminopentan
ATE540009T1 (de) Verfahren zur herstellung von ethylen
DE602005015174D1 (de) Verfahren zur herstellung von montelukast-natrium
DE502006005581D1 (de) Ukmischungen, ein verfahren zu deren herstellung, verfahren zur herstellung von verbund-formteilen und deren verwendung
ATE486857T1 (de) Verfahren zur herstellung von telmisartan
ATE444950T1 (de) Verfahren zur herstellung von 1-amino-3,5- dimethyladamantan-hydrochlorid
DE112005003709A5 (de) Mischung zur Herstellung von selbstverdichtendem Beton
WO2019224713A3 (en) Monospecific and multispecific anti-tmeff2 antibodies and there uses
ATE354583T1 (de) Verfahren zur herstellung c-7 substituierter 5- androstene
ATE518828T1 (de) Ein-topf-verfahren zur herstellung von 3-(2,2,2- trimethylhydrazinium)propionat-dihydrat
DE602005002597D1 (de) Verfahren zur Isomerisierung von einer C7-Fraktion mit Koproduktion von einer cyclischen Methylcyclohexan-reichen Fraktion
ATE391115T1 (de) Verfahren zur herstellung von diketenacetalen
AR058253A1 (es) Procedimiento para la preparacion de ferri-succinilcaseina
ATE489352T1 (de) Verfahren zur herstellung von brenztraubensäure
ATE468349T1 (de) GROßTECHNISCHES VERFAHREN ZUR HERSTELLUNG VON 17- HYDROXY-6BETA, 7BETA, 15BETA,16BETA-BISMETHYLEN-3-OXO-17ALPHA-PREGN-4 EN-21-CARBONSÄURE-GAMMA- LACTON UND SCHLÜSSELZWISCHENPRODUKTE FÜR DIESES VERFAHREN
ATE352549T1 (de) Verfahren zur herstellung von desloratadin
ATE553080T1 (de) Verkürztes verfahren zur herstellung von l- lobelin
ATE554064T1 (de) Verfahren zur herstellung von entacapon
ATE550422T1 (de) Verfahren zur herstellung von mycophenolsäure mit penicillium arenicola bicc7673
ATE501104T1 (de) Verfahren zur herstellung von 1,2,2,2-tetrafluor- ethyl-difluor-methylether
ATE459591T1 (de) Verbessertes verfahren zur herstellung von (e,z)- 7,8-cyclohexadecen-1-on
DE602006013688D1 (de) Neues verfahren zur herstellung von thoc
ATE380183T1 (de) Verfahren zur herstellung von phenyltetrazolderivaten